Arcadia Biosciences, Inc.
RKDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $856 | -$4,458 | $2,599 | -$4,064 |
| Dep. & Amort. | $7 | $15 | $117 | $21 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $86 | $0 | $117 |
| Change in WC | $830 | -$659 | -$701 | $379 |
| Other Non-Cash | -$1,950 | $2,983 | -$3,603 | $1,338 |
| Operating Cash Flow | -$257 | -$2,033 | -$1,588 | -$2,209 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $500 | $2,523 |
| Other Inv. Act. | $0 | $250 | $0 | -$8 |
| Investing Cash Flow | $0 | $250 | $500 | $2,515 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $0 | $5 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1 | $0 | $5 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$256 | -$1,783 | -$1,083 | $306 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,376 | $3,159 | $4,242 | $3,936 |
| End Cash | $1,120 | $1,376 | $3,159 | $4,242 |
| Free Cash Flow | -$257 | -$2,033 | -$1,588 | -$2,209 |